Callaway Golf (ELY) Down to Strong Sell on Soft Q4, Fx Woes - Analyst Blog

On Mar 6, Zacks Investment Research downgraded Callaway Golf Co. ELY to a Zacks Rank #5 (Strong Sell) as estimates have been going down since the company reported lower-than-expected fourth-quarter 2014 results on Jan 29.

Why the Downgrade?

Although Callaway’s fourth-quarter top line and bottom line improved year over year, it missed management expectations. Fourth-quarter loss of 55 cents was wider than the Zacks Consensus Estimate of a loss of 54 cents. Sales of $134.6 million also missed the Zacks Consensus Estimate of $139.0 million by 3.2%. An unusually cold weather hurt results in the quarter.

Analysts are concerned about the unfavorable foreign exchange headwinds that are affecting Callaway’s top line sine more than 50% of the company operations are based outside U.S.

Almost all the estimates for first-quarter 2015 were revised lower over the last 60 days and as a result the Zacks Consensus Estimate slid 28.2% to 28 cents.

Full-Year 2015 Guidance Lowered

Callaway lowered the 2015 guidance during the fourth-quarter 2014 earnings conference call. It expects significant foreign currency headwinds during the 2015. Earnings per share are projected to grow approximately 40% to 90% year over year instead of 100% expected previously. The company expects sales growth of 1–4% as against 2–3%. 

Stocks to Consider

Investors interested in the leisure & recreation services sector may consider stocks like Black Diamond Inc. BDE, Pool Corp. POOL and Smith & Wesson Holding Corp. SWHC. All these stocks carry a Zacks Rank #2 (Buy).


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CALLAWAY GOLF (ELY): Free Stock Analysis Report
 
POOL CORP (POOL): Free Stock Analysis Report
 
BLACK DIAMOND (BDE): Free Stock Analysis Report
 
SMITH & WESSON (SWHC): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement